2004
DOI: 10.1200/jco.2004.22.14_suppl.4245
|View full text |Cite
|
Sign up to set email alerts
|

A phase II study of irinotecan and docetaxel with concurrent radiotherapy as preoperative treatment in resectable esophageal cancer

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles